STERIS faces earnings test as AST destocking questions persist By Investing.com

STERIS (STE) is set to report its fiscal first-quarter earnings, with investors keenly watching its Applied Sterilization Technologies (AST) segment for signs of stabilization after recent destocking. Analysts anticipate earnings of $2.50 per share and revenue of $1.5 billion, reflecting year-over-year growth but a sequential decline. Wall Street maintains a bullish outlook on the company, expecting the company's capital expenditures to widen its market moat rather than diminish value.